Element Capital Management LLC Acquires New Holdings in Philip Morris International Inc. $PM

Element Capital Management LLC acquired a new stake in shares of Philip Morris International Inc. (NYSE:PMFree Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 7,900 shares of the company’s stock, valued at approximately $1,429,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Capital World Investors increased its stake in Philip Morris International by 2.8% during the 4th quarter. Capital World Investors now owns 132,355,726 shares of the company’s stock valued at $21,230,315,000 after buying an additional 3,579,399 shares during the period. BlackRock Inc. lifted its stake in shares of Philip Morris International by 0.4% in the 2nd quarter. BlackRock Inc. now owns 108,039,522 shares of the company’s stock worth $19,545,430,000 after acquiring an additional 444,449 shares during the period. Capital International Investors boosted its holdings in shares of Philip Morris International by 13.7% in the fourth quarter. Capital International Investors now owns 101,377,875 shares of the company’s stock valued at $16,262,967,000 after acquiring an additional 12,227,004 shares in the last quarter. Capital Research Global Investors boosted its holdings in shares of Philip Morris International by 25.3% in the fourth quarter. Capital Research Global Investors now owns 54,559,706 shares of the company’s stock valued at $8,751,407,000 after acquiring an additional 11,013,173 shares in the last quarter. Finally, GQG Partners LLC acquired a new position in shares of Philip Morris International during the second quarter valued at approximately $8,220,008,000. Institutional investors own 78.63% of the company’s stock.

Key Philip Morris International News

Here are the key news stories impacting Philip Morris International this week:

  • Positive Sentiment: FDA authorization strengthens ZYN growth prospects. The FDA authorized 11 ZYN ULTRA nicotine-pouch products, expanding PM’s U.S. smoke-free portfolio and supporting its longer-term shift away from combustible tobacco. Smoke-free products, led by ZYN and IQOS, now account for more than 41% of revenue, offering a potential multiyear growth runway. Philip Morris’ ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push
  • Positive Sentiment: Manufacturing agreements with Altria may improve efficiency. PM and Altria entered reciprocal contract-manufacturing arrangements involving cigarette production. The agreements should increase operational flexibility and manufacturing efficiency, with initial shipments expected in 2027. The partnership may provide longer-term cost and supply-chain benefits for PM, despite limited near-term earnings impact. Altria and Philip Morris International Sign Contract Manufacturing Deals
  • Positive Sentiment: Pricing power and shareholder returns remain supportive. PM’s portfolio spans IQOS, ZYN, VEEV One, and Marlboro, helping it maintain premium pricing amid uncertain economic conditions. Analysts highlight strong free cash flow, lower debt leverage, and the possibility of another dividend increase in September. Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets
  • Neutral Sentiment: Near-term financial impact from the Altria deal is expected to be limited. Both companies said the manufacturing arrangements are not expected to materially affect 2026 results, so investors may need to wait until 2027 for measurable benefits. Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
  • Negative Sentiment: Valuation leaves less room for disappointment. PM’s smoke-free growth and defensive cash flows have attracted a premium valuation, creating downside risk if product adoption, regulatory momentum, or earnings growth falls short of expectations.

Analysts Set New Price Targets

Several equities research analysts recently commented on PM shares. Weiss Ratings reissued a “buy (b)” rating on shares of Philip Morris International in a report on Monday, August 17th. Morgan Stanley lifted their price target on Philip Morris International from $200.00 to $215.00 and gave the company an “overweight” rating in a research report on Thursday, July 23rd. Barclays upped their price objective on Philip Morris International from $205.00 to $225.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. Stifel Nicolaus raised their target price on Philip Morris International from $195.00 to $205.00 and gave the company a “buy” rating in a research note on Thursday, July 23rd. Finally, Needham & Company LLC lifted their target price on Philip Morris International from $200.00 to $215.00 and gave the stock a “buy” rating in a report on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $205.89.

Read Our Latest Analysis on Philip Morris International

Philip Morris International Stock Performance

Shares of NYSE:PM opened at $194.00 on Wednesday. The stock has a market capitalization of $302.36 billion, a price-to-earnings ratio of 27.87, a PEG ratio of 2.31 and a beta of 0.38. Philip Morris International Inc. has a 1-year low of $142.11 and a 1-year high of $207.76. The company has a 50 day moving average price of $186.42 and a 200 day moving average price of $178.55.

Philip Morris International (NYSE:PMGet Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.05 by $0.15. Philip Morris International had a negative return on equity of 163.41% and a net margin of 11.06%.The company had revenue of $11.19 billion for the quarter, compared to analysts’ expectations of $10.60 billion. During the same quarter in the prior year, the company earned $1.89 earnings per share. The firm’s revenue was up 10.4% on a year-over-year basis. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, sell-side analysts expect that Philip Morris International Inc. will post 8.33 EPS for the current fiscal year.

Philip Morris International Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, July 20th. Stockholders of record on Thursday, June 25th were given a dividend of $1.47 per share. The ex-dividend date of this dividend was Thursday, June 25th. This represents a $5.88 dividend on an annualized basis and a dividend yield of 3.0%. Philip Morris International’s payout ratio is 84.48%.

Philip Morris International Profile

(Free Report)

Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.

Featured Articles

Want to see what other hedge funds are holding PM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Philip Morris International Inc. (NYSE:PMFree Report).

Institutional Ownership by Quarter for Philip Morris International (NYSE:PM)

Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.